| Product Code: ETC11316271 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market - Industry Life Cycle |
3.4 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market - Porter's Five Forces |
3.5 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume Share, By Packaging Type, 2021 & 2031F |
3.7 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccinations against cholera |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Growing demand for safe and effective vaccines |
4.3 Market Restraints |
4.3.1 High cost associated with the development and production of recombinant vaccines |
4.3.2 Limited accessibility to healthcare facilities in certain regions |
4.3.3 Concerns regarding the side effects or efficacy of the vaccine |
5 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Trends |
6 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market, By Types |
6.1 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Oral Vaccines, 2021 - 2031F |
6.1.4 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Injectable Vaccines, 2021 - 2031F |
6.1.5 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Combination Vaccines, 2021 - 2031F |
6.2 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market, By Packaging Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Vials, 2021 - 2031F |
6.2.3 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Ampoules, 2021 - 2031F |
6.2.4 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Pre-filled Syringes, 2021 - 2031F |
6.3 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Specialty Pharmacies, 2021 - 2031F |
6.3.4 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Healthcare Facilities, 2021 - 2031F |
6.4.3 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Government Immunization Programs, 2021 - 2031F |
6.4.4 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
7 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Import-Export Trade Statistics |
7.1 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Export to Major Countries |
7.2 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Imports from Major Countries |
8 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Key Performance Indicators |
8.1 Number of vaccination campaigns conducted in Israel |
8.2 Percentage of population vaccinated against cholera |
8.3 Research and development investments in improving the vaccine efficacy |
8.4 Number of reported cholera cases in Israel |
8.5 Level of collaboration between government agencies and vaccine manufacturers |
9 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market - Opportunity Assessment |
9.1 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Opportunity Assessment, By Packaging Type, 2021 & 2031F |
9.3 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market - Competitive Landscape |
10.1 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Revenue Share, By Companies, 2024 |
10.2 Israel Whole Cell Cholera Vaccine Recombinant B Subunit Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here